A5062826255- Diabetes, Cardiovascular Risks, and Lipoproteins
- Diabetes Management and Research
- Diabetes Treatment and Management
- Diabetes and associated disorders
- Pancreatic function and diabetes
- Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Bariatric Surgery and Outcomes
- Diet and metabolism studies
- Metabolism, Diabetes, and Cancer
- Cardiovascular Function and Risk Factors
- Pharmacology and Obesity Treatment
- Lipoproteins and Cardiovascular Health
- Obesity and Health Practices
- Blood Pressure and Hypertension Studies
- Intravenous Infusion Technology and Safety
- Musculoskeletal pain and rehabilitation
- Lipid metabolism and disorders
- Cardiovascular Syncope and Autonomic Disorders
- Cancer, Lipids, and Metabolism
- Melanoma and MAPK Pathways
- Receptor Mechanisms and Signaling
- Muscle metabolism and nutrition
- Nutritional Studies and Diet
- Acute Ischemic Stroke Management
- Diabetes Management and Education
University of Pittsburgh
2021-2025
VA Pittsburgh Healthcare System
2014-2025
Veterans Health Administration
2021
SUNY Upstate Medical University
2019
Upstate University Hospital
2019
Syracuse University
2018
Thomas Jefferson University Hospital
2005-2010
University of Pennsylvania
2008-2010
University of Pennsylvania Health System
2010
Hospital of the University of Pennsylvania
2005
A recent case report by Sahota and colleagues has provided new insights into treatment of dysglycemia via dopamine (DA) receptor stimulation in the setting autoimmune diabetes [1].Briefly, a patient with was diagnosed pituitary prolactinoma, resulting cabergoline, an agonist DA D2-like receptors, alongside preexisting medications. Over time, switched to cabergoline monotherapy which reversed his insulin requirement. This led significantly improved glycemic control revised diagnosis latent...
Objective: To explore the clinical consequences and potential root causes of insulin pump-associated adverse events (AEs) reported in Food Drug Administration's Manufacturer User Facility Device Experience (MAUDE) database. Research Design Methods: Qualitative template analysis narrative data a 20% stratified random sample (n = 2429) AEs that occurred during first 6 months 2020 involving five pump models marketed at time: (1) MiniMed™ 670G, (2) 630G, (3) Omnipod®, (4) Omnipod DASH®, (5)...
Background . Roux-en-Y gastric bypass (RYGB) is a commonly performed, effective bariatric procedure; however, rarely, complications such as postprandial hypoglycemia due to noninsulinoma pancreatogenous syndrome (NIPHS) may ensue. Management of refractory NIPHS challenging. We report case that was successfully treated with RYGB reversal. Case Report A 58-year-old male history nine months earlier for morbid obesity presented evaluation postprandial, hypoglycemic seizures. Testing insulin...
Objective: Explore alarm signals cited in insulin pump-associated adverse events (AEs), describe the clinical consequences and other root cause informing remarks that cooccurred with signals, identify opportunities for improvements to patient education, instructional materials, systems prevent future AEs. Research Design Methods: We explored type, frequency, associated of a pre-coded data set 2294 AEs involving MiniMed 670G, 630G, t:slim X2. also top 10 most frequently signals. Results:...
Perform a cost-effectiveness analysis of addition subcutaneous semaglutide versus empagliflozin to usual treatment for patients with Type 2 diabetes and cardiovascular disease in US setting.
Objective: To explore insulin pump-associated severe adverse events (SAEs) involving intensive care unit (ICU) admissions and deaths examine the impact of COVID-19 pandemic on these SAEs. Methods: Qualitative template analysis narrative data in reported SAEs occurring between May 1, 2019, January 31, 2021, MiniMed 670G, 630G, Omnipod, Omnipod DASH, t:slim X2 pumps. Results: Over 21-month measurement period, 460 an ICU admission 288 a death were to Food Drug Administration. Problems with pump...
Introduction: Roux-en-Y gastric bypass (RYGB) is the most commonly performed bariatric surgery in United States. One rare late postoperative complication postprandial neuroglycopenia due to noninsulinoma pancreatogenous hypoglycemia syndrome (NIPHS). Prior reports of surgical management NIPHS include gradient-guided partial or total pancreatectomy. We report a case reversal for successful treatment refractory NIPHS. Case Report: A 58-year-old white male with history ischemic cardiomyopathy,...